Sideinnhold
A -
B -
C -
D -
E -
F -
G -
H -
I -
J -
K -
L -
M -
N -
O -
P -
Q -
R -
S -
T -
U -
V -
X -
Y -
Z
(S) = sykehuslegemiddel
| memantin | Alzheimer | 2010 |
|---|
| Efient | prasugrel | Aterotrombotiske hendelser | 2010 |
|---|
|
Eklira Genuair | aklidiniumbromid | KOLS | 2012 |
|---|
| Eliquis | apixaban | Slagprofylakse ved atrieflimmer | 2013 |
|---|
| Eliquis | apixaban | Tromboseprofylakse ved kirurgi | 2011 |
|---|
|
Elocta (S) | efmoroktokog alfa | Hemofili A | 2016 |
|---|
|
Elvanse | lisdeksamfetamin | ADHD | 2014
|
|---|
Emgality
| galcanezumab
| Kronisk migrene
| 2020 |
|---|
|
Empliciti (S) | elotuzumab | Myelomatose | 2016 |
|---|
| Empliciti (S) | elotuzumab | Myelomatose subgruppe | 2019 |
|---|
| Emselex | darifenacin | Inkontinens | 2005 |
|---|
|
Enbrel | etanercept | Leddgikt | 2005 |
|---|
Enerzair
| indakaterol/glykopyrronium/mometason
| Astma
| 2020
|
|---|
Entresto
Notat - endrede forhold | sakubitril, valsartan
| Hjertesvikt | 2017 2017 |
|---|
| Entresto - oppdatering | sakubitril, valsartan | Hjertesvikt | 2018 |
|---|
|
Entyvio (S) | vedolizumab | Mb. Chrohn | 2015 |
|---|
| Entyvio (S) | vedolizumab | Ulcerøs kolitt | 2015 |
|---|
|
Epclusa (S) | sofosbuvir/velpatasvir | Hepatitt C - GT2 | 2016 |
|---|
| Epclusa (S) | sofosbuvir/velpatasvir | Hepatitt C - GT3 | 2017 |
|---|
| Epclusa (S) | sofosbuvir/velpatasvir | Hepatitt C - GT1 | 2017 |
|---|
| adrenalin | | 2010
|
|---|
Epistatus
| midazolam
| Epilepsi
| 2020
|
|---|
| Erleada (S) | apalutamid | Prostatakreft | 2020 |
|---|
| Esmya | ulipristalacetat | Myomer | 2013 |
|---|
| Esmya | ulipristalacetat | Myomer intermitterende bruk | 2016 |
|---|
| Esperoct (S) | turoktokog alfa pegol | Hemofili A | 2020 |
|---|
| Exviera | dasabuvir | Hepatitt C | 2015 |
|---|
| Eylea | aflibercept | Våt AMD | 2013 |
|---|
| ezetimib | Hyperkolesterolemi | 2007 |
|---|
